Company profile
Biome Grow Inc.
OTC: BIOIF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 29
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ 3-yr revenue growth, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$8.4M
Employees
5
as of 2026-08-28
Market cap
$56.2k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2022
Net income-$8.4M-10.9M CAD2022
Operating income-$468.8k-610.0k CAD2022
Total assets$341.6k462.7k CAD2022
Liabilities$3.6M4.9M CAD2022
Equity-$3.3M-4.4M CAD2022
Revenue trend
FY2017 – FY2022 · USD
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Biome Grow Inc.’s revenue?
Biome Grow Inc. booked $0 in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Wesana Health Holdings Inc.——Pathfinder Cell Therapy, Inc.——PaxMedica, Inc. Common Stock——Street Capital Inc.18DMera Pharmaceuticals, Inc.——Hero Technologies Inc.——Key facts
CEOKhurram Malik
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: BIOIF
Employees5
IPO date2015-10-29
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.